Skip to Content
UW Health SMPH
American Family Children's Hospital
SHARE TEXT
Gary S. Wood, MD close
Gary S. Wood, MD

Gary S. Wood, MD Print Friendly Page

Chair, Department of Dermatology
Faculty, University of Wisconsin School of Medicine and Public Health

Gary S. Wood, MD is triple board certified in dermatology, dermatopathology and anatomic pathology. He is an internationally recognized expert in cutaneous lymphomas, pseudolymphomas, parapsoriasis and related conditions. He has served on the faculty of Stanford University and Case Western Reserve University. In 2001, he was recruited here as the Geneva F. and Sture Johnson Professor and Head of the Division of Dermatology. In 2002, he became the founding Chair of the new Department of Dermatology. Under his leadership, the department has grown to more than 20 faculty involved in diverse clinical and educational programs. It has ranked among the top NIH-funded dermatology research programs for the past several years.

 

Dr. Wood has served as President of the International Society for Cutaneous Lymphomas, President of the National Association of VA Dermatologists, and has held several other leadership positions in national and international professional organizations. He is a recipient of the prestigious Marion B. Sulzberger Research Award from the American Academy of Dermatology. He has authored more than 350 articles, chapters and abstracts, mostly focused on cutaneous oncology. He is leader of the UW Carbone Comprehensive Cancer Center’s non-melanoma skin cancer disease oriented work group (NMSC DOWG) and director of UW Health’s Cutaneous Lymphoma Clinic where he cares for patients referred from throughout Wisconsin and the Midwest. He also directs the Immunodiagnosis Lab, a component of the Dermatopathology Service, that offers comprehensive diagnostic testing for skin diseases.

Specialties

Dermatology

Dermatopathology

UW Health Clinics

West Clinic
(608) 265-0700 | (800) 323-8942 | Map
West Clinic
(608) 265-1681 | (800) 323-8942 | Map

Hospital Affiliation(s)

University of Wisconsin Hospital and Clinics (primary)

Languages Spoken

English
Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.

UW School of Medicine and Public Health

Department of Dermatology

Professional Certifications and Education

Board Certification Dermatology
Dermatopathology
Anatomic Pathology
Fellowship Stanford University Medical Center, Stanford, CA
Residency Stanford University Medical Center, Stanford, CA
Internship Stanford University Medical Center, Stanford, CA
Medical School University of Illinois at Chicago, Chicago, IL, 1979

Awards/Honors

Best Doctors® in America 2014

Best Doctors® in America 2013

Best Doctors® in America 2011


Procedures

Our doctors provide a wide range of services. The following list represents some, but not all, of the procedures offered by this physician.

Programs & Conditions

PubMed Articles
Wu J Salva KA Wood GS . c-CBL E3 Ubiquitin Ligase is Over-Expressed in Cutaneous T-Cell Lymphoma: Its Inhibition Promotes Activation Induced Cell Death. J Invest Dermatol. 2014 Aug 20;
[PubMed ID: 25140833]
Reeder MJ Wood GS . Drug-Induced Pseudo-Sezary Syndrome: A Case Report and Literature Review. Am J Dermatopathol. 2014 Jul 15;
[PubMed ID: 25033012]
Ndiaye MA Nihal M Wood GS Ahmad N . Skin, reactive oxygen species, and circadian clocks. Antioxid Redox Signal. 2014 Jun 20;20(18):2982-96
[PubMed ID: 24111846]
Nihal M Wu J Wood GS . Methotrexate inhibits the viability of human melanoma cell lines and enhances Fas/Fas-ligand expression, apoptosis and response to interferon-alpha: Rationale for its use in combination therapy. Arch Biochem Biophys. 2014 May 23;
[PubMed ID: 24862567]
Wu J Salva KA Stutz N Longley BJ Spiegelman VS Wood GS . Quantitative gene analysis of methylation and expression (Q-GAME) in fresh or fixed cells and tissues. Exp Dermatol. 2014 May;23(5):304-9
[PubMed ID: 24646432]
Nihal M Ahmad N Wood GS . SIRT1 is upregulated in cutaneous T-cell lymphoma, and its inhibition induces growth arrest and apoptosis. Cell Cycle. 2014 Feb 15;13(4):632-40
[PubMed ID: 24343700]
Kadin ME Hughey LC Wood GS . Large-cell transformation of mycosis fungoides-differential diagnosis with implications for clinical management: a consensus statement of the US Cutaneous Lymphoma Consortium. J Am Acad Dermatol. 2014 Feb;70(2):374-6
[PubMed ID: 24438952]
Salva KA Stenstrom M Breadon JY Odland PB Bennett D Longley J Wood GS . Possible association of cutaneous Rosai-Dorfman disease and chronic Crohn disease: a case series report. JAMA Dermatol. 2014 Feb;150(2):177-81
[PubMed ID: 24305684]
Salva KA Haemel AK Pincus LB Liu J Sundram U Guitart J Longley BJ Wood GS . Expression of CD31/PECAM-1 (platelet endothelial cell adhesion molecule 1) by blastic plasmacytoid dendritic cell neoplasms. JAMA Dermatol. 2014 Jan;150(1):73-6
[PubMed ID: 24225899]
Chamcheu JC Afaq F Syed DN Siddiqui IA Adhami VM Khan N Singh S Boylan BT Wood GS Mukhtar H . Delphinidin, a dietary antioxidant, induces human epidermal keratinocyte differentiation but not apoptosis: studies in submerged and three-dimensional epidermal equivalent models. Exp Dermatol. 2013 May;22(5):342-8
[PubMed ID: 23614741]
Kreul SM Havighurst T Kim K Mendonça EA Wood GS Snow S Borich A Verma A Bailey HH . A phase III skin cancer chemoprevention study of DFMO: long-term follow-up of skin cancer events and toxicity. Cancer Prev Res (Phila). 2012 Dec;5(12):1368-74
[PubMed ID: 23060038]
Stutz N Johnson RD Wood GS . The Fas apoptotic pathway in cutaneous T-cell lymphomas: frequent expression of phenotypes associated with resistance to apoptosis. J Am Acad Dermatol. 2012 Dec;67(6):1327.e1-10
[PubMed ID: 22884443]
Chamcheu JC Wood GS Siddiqui IA Syed DN Adhami VM Teng JM Mukhtar H . Progress towards genetic and pharmacological therapies for keratin genodermatoses: current perspective and future promise. Exp Dermatol. 2012 Jul;21(7):481-9
[PubMed ID: 22716242]
Wu J Siddiqui J Nihal M Vonderheid EC Wood GS . Structural alterations of the FAS gene in cutaneous T-cell lymphoma (CTCL). Arch Biochem Biophys. 2011 Apr 15;508(2):185-91
[PubMed ID: 21036138]
Nihal M Stutz N Schmit T Ahmad N Wood GS . Polo-like kinase 1 (Plk1) is expressed by cutaneous T-cell lymphomas (CTCLs), and its downregulation promotes cell cycle arrest and apoptosis. Cell Cycle. 2011 Apr 15;10(8):1303-11
[PubMed ID: 21436619]
Wu J Wood GS . Reduction of Fas/CD95 promoter methylation, upregulation of Fas protein, and enhancement of sensitivity to apoptosis in cutaneous T-cell lymphoma. Arch Dermatol. 2011 Apr;147(4):443-9
[PubMed ID: 21173302]
Nihal M Roelke CT Wood GS . Anti-melanoma effects of vorinostat in combination with polyphenolic antioxidant (-)-epigallocatechin-3-gallate (EGCG). Pharm Res. 2010 Jun;27(6):1103-14
[PubMed ID: 20232120]
Nihal M Ahsan H Siddiqui IA Mukhtar H Ahmad N Wood GS . (-)-Epigallocatechin-3-gallate (EGCG) sensitizes melanoma cells to interferon induced growth inhibition in a mouse model of human melanoma. Cell Cycle. 2009 Jul 1;8(13):2057-63
[PubMed ID: 19502799]
Wu J Nihal M Siddiqui J Vonderheid EC Wood GS . Low FAS/CD95 expression by CTCL correlates with reduced sensitivity to apoptosis that can be restored by FAS upregulation. J Invest Dermatol. 2009 May;129(5):1165-73
[PubMed ID: 18923451]
Fett NM Siddiqui J Creswell CH Zhang D Lloyd R Wood GS . Adult T-cell leukemia/lymphoma in a patient from Romania: a case report and review of the literature. J Cutan Pathol. 2008 Oct;35 Suppl 1:32-7
[PubMed ID: 18544058]